Table 4.
Parameter | Coefficient | SE | 95% CI | p-value | |
---|---|---|---|---|---|
Low | High | ||||
Within-person distressa | −0.24 | 0.13 | −0.50 | 0.01 | 0.059 |
Between-person distressa | −2.27 | 0.29 | −2.84 | −1.70 | <0.001 |
Cancer controlb | 0.04 | 0.01 | 0.01 | 0.07 | 0.005 |
Baseline distressb | 0.93 | 0.23 | 0.49 | 1.37 | <0.001 |
Baseline sexual functionb | 0.52 | 0.02 | 0.47 | 0.57 | <0.001 |
Time | 1.48 | 0.17 | 1.15 | 1.82 | <0.001 |
Educationb | 0.56 | 0.19 | 0.20 | 0.92 | 0.003 |
Ageb | −0.47 | 0.08 | −0.64 | −0.31 | <0.001 |
Radiotherapyb,c | 8.80 | 1.50 | 5.85 | 11.75 | <0.001 |
Hormone therapyb,c | −9.08 | 1.77 | −12.54 | −5.62 | <0.001 |
Intermediate riskc | −4.29 | 1.28 | −6.80 | −1.79 | 0.001 |
High riskc | −9.66 | 1.69 | −12.98 | −6.34 | <0.001 |
Note: SE = standard error; we controlled for recruitment site although statistics for that effect are not reported as there is no meaningful referent group
Predictor variables were time-lagged
Covariates were grand-mean centered
Referent groups were surgery, no hormone therapy, and low-risk